News & Press Releases

Filter
417 found
Prof. Djimde and students at WANECAM Molecular Biology Workshop MRC Gambia

New study details safety and efficacy of re-treatment with Pyramax®

23 Oct 2015
R&D

Comic books, science fiction and colour inspire two of ‘175 Faces of Chemistry’

09 Oct 2015

Nobel in Medicine awarded to parasitic disease drug pioneers

05 Oct 2015
General

Leader in the fight against malaria passes away

21 Sep 2015
General

WHO awards over $1 million to MMV’s ‘Exploiting the Pathogen Box’ project

19 Aug 2015
Open source, R&D

Call to nominate forward-thinking malaria heroes

13 Aug 2015
General

MMV welcomes launch of WHO P. vivax technical brief

29 Jul 2015
General

Pre-clinical assessment of exciting new malaria drug candidate published

16 Jul 2015
R&D

OZ439 recognized as a high-impact innovation to transform global health

16 Jul 2015
R&D

MMV wins Tim Berners-Lee’s Open Data Innovation Award

10 Jul 2015
R&D, Open source

New compound has the potential to treat malaria patients in a single dose

17 Jun 2015
Partner, R&D

GHIT, Takeda and MMV progress first-in-class antimalarial DSM265 to patient trials in Peruvian Amazon

05 Jun 2015
Partner, R&D
Dr David Reddy, CEO, MMV and Dr Bernard Pécoul, CEO, DNDi

DNDi passes the ball to MMV

22 May 2015
Access & product management

MMV delivers statement at 68th World Health Assembly

19 May 2015
General

MMV joins the Asia Pacific Malaria Elimination Network (APMEN)

23 Apr 2015
Access & product management, Partner

MMV recognizes outstanding achievements of ISMO partners

09 Apr 2015
Access & product management

Merck Serono and MMV sign agreement to develop potential antimalarial therapy

01 Apr 2015
Partner, R&D

MMV welcomes continued Australian government support

24 Mar 2015
Donors

MMV awards challenge grants to seven Malaria Box recipients

06 Mar 2015
R&D, Open source

Japanese global health fund announces new investment in promising compounds for antimalarial drug discovery

05 Feb 2015
R&D

Independent Safety Monitoring Board assessment enables recruitment of 2-5 year olds into OZ439/PQP Phase IIb trial

20 Jan 2015
R&D

First Chair of MMV’s ESAC receives knighthood

12 Jan 2015
R&D

WHO’s much-awaited World Malaria Report reveals progress in the fight against malaria

10 Dec 2014
General

Three new roads leading to a common pathway

09 Dec 2014
R&D

MMV announces collaborations with Cipla and Strides

27 Nov 2014
General

Call for stories and ideas for GMAP2

20 Nov 2014
General, Partner

Child-friendly antimalarial reaches new landmark of 250 million treatments delivered

19 Nov 2014
Access & product management

MMV partner Prof. Luiz Carlos Dias receives Santander University Award

13 Nov 2014
R&D

300,000 vials of injectable artesunate delivered to Kenya and Nigeria

04 Nov 2014
Access & product management

Guilin’s SP+AQ added to WHO’s “List of Prequalified Products”

29 Oct 2014
Access & product management

Pyramax now registered in Cambodia

15 Oct 2014
Access & product management

NIH scientist Dr Martin John Rogers has passed away

09 Sep 2014
General

MMV organizes international malaria conference in Berlin

01 Jul 2014
R&D

MMV launches the Seasonal Malaria Chemoprevention Tool Kit

29 Apr 2014
Access & product management

GSK and MMV announce start of Phase III programme of tafenoquine

28 Apr 2014
R&D

MMV and Merck Serono join forces in antimalarial drug discovery

24 Feb 2014
Partner, R&D

MMV and partners call for compounds to fill the Pathogen Box

18 Feb 2014
Open source, R&D

Potential new antimalarial drug identified at the University of Dundee

06 Feb 2014
R&D
© iStock.com/combojan fatur

Takeda collaborates with MMV through GHIT Fund

24 Dec 2013
Partner

Breakthrough Therapy designation for potential new anti-relapse medicine for malaria

20 Dec 2013
Access & product management, R&D

Tafenoquine successfully completes Phase IIb clinical trials

19 Dec 2013
R&D

State-of-the-art laboratory to study new antimalarials opens in Jakarta

10 Dec 2013
R&D

Rise in R&D funding could set the stage for malaria eradication

10 Dec 2013
General

New antimalarial drug target identified

29 Nov 2013
R&D

Partners commit to bolstering open source research

27 Nov 2013
Open source, R&D

MMV signs MoU with Takeda and GHIT (Japan)

11 Nov 2013
R&D

MMV partner receives PLOS Accelerating Science Award

23 Oct 2013
Open source, R&D

First-ever drug compound developed on African soil, an antimalarial, to move to human trials

08 Oct 2013
R&D

Eurartesim® begins ‘real-life’ post African registration safety and effectiveness testing

03 Oct 2013
Access & product management

Campaign launched to help eliminate malaria deaths

23 Sep 2013
General

MMV’s ‘Challenge Model’ creates a buzz in Australia

16 Sep 2013
R&D

Potential new class of antimalarials now open source

10 Sep 2013
Open source, R&D

MMV receives funding to develop drugs to accelerate malaria eradication

22 Aug 2013
Donors

DFID pledges further support for MMV

22 Aug 2013
Donors

Australian first to advance malaria medicines

19 Aug 2013
Donors

African research is rising

12 Jul 2013
R&D

Japan launches bold effort to fight neglected diseases

31 May 2013
R&D

WHO approves injectable artesunate 30mg & 120mg

24 May 2013
Access & product management

MMV welcomes appointment of UK MP as Global Advocate for Malaria

17 May 2013
General

World Malaria Day 2013

25 Apr 2013
General

Pages